85
Participants
Start Date
October 11, 2018
Primary Completion Date
May 7, 2020
Study Completion Date
July 1, 2020
Valaciclovir
Participants will self-administer Valaciclovir 1 gram three times daily for 8 weeks.
Placebo capsules (containing Avicel blend)
Participants will self-administer two matching placebo capsules (containing Avicel blend) three times daily for 8 weeks.
Belfast Health and Social Care Trust, Belfast
Collaborators (1)
Northern Ireland Clinical Trials Unit
OTHER
Queen's University, Belfast
OTHER
Belfast Health and Social Care Trust
OTHER